Work

Lebrikizumab (Ebglyss) for Atopic Dermatitis

Year: 2024

Type: article

Source: The medical letter on drugs and therapeutics/The medical letter

DOI: 10.58347/tml.2024.1715b

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403717472

FWCI:

Cites:

Cited by:

Related to: 10